(Q57313076)

English

Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-

article

Statements

Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)- (English)
0 references
0 references
0 references
David A. Morrow
0 references
Benjamin M. Scirica
0 references
Keith A.A. Fox
0 references
Gail Berman
0 references
John Strony
0 references
Marc P. Bonaca
0 references
Polly Fish
0 references
Carolyn H. McCabe
0 references
September 2009
0 references
158
0 references
3
0 references
335-341.e3
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit